Revista de Ciências Biomédicas e Farmacêuticas

Utilizing lung Ultrasound for Predicting Success in COVID-19 Patients Having Extracorporeal Membrane Oxygenation

Abstract

Jennifer Brusko

The COVID-19 pandemic has presented unprecedented challenges to healthcare systems worldwide. In severe cases, the virus can lead to Acute Respiratory Distress Syndrome (ARDS), necessitating advanced interventions such as Extracorporeal Membrane Oxygenation (ECMO). ECMO provides temporary mechanical support to the heart and lungs, allowing them to rest and heal. However, determining the success of ECMO in COVID-19 patients has become a critical concern. Lung ultrasound, a non-invasive imaging technique, has gained traction as a potential tool for predicting the success of ECMO in these patients. This article delves into the application of lung ultrasound in predicting the outcomes of COVID-19 patients undergoing ECMO.